Annual Total Liabilities
$2.60 B
+$642.40 M+32.76%
31 December 2023
Summary:
Ionis Pharmaceuticals annual total liabilities is currently $2.60 billion, with the most recent change of +$642.40 million (+32.76%) on 31 December 2023. During the last 3 years, it has risen by +$956.91 million (+58.12%). IONS annual total liabilities is now at all-time high.IONS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.42 B
-$8.80 M-0.36%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly total liabilities is currently $2.42 billion, with the most recent change of -$8.80 million (-0.36%) on 30 September 2024. Over the past year, it has dropped by -$199.88 million (-7.63%). IONS quarterly total liabilities is now -7.63% below its all-time high of $2.62 billion, reached on 30 September 2023.IONS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.8% | -7.6% |
| 3 y3 years | +58.1% | +28.4% |
| 5 y5 years | +75.8% | +73.1% |
IONS Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +58.1% | -7.6% | +33.7% |
| 5 y | 5 years | at high | +75.8% | -7.6% | +73.1% |
| alltime | all time | at high | >+9999.0% | -7.6% | >+9999.0% |
Ionis Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.42 B(-0.4%) |
| June 2024 | - | $2.43 B(-1.6%) |
| Mar 2024 | - | $2.47 B(-5.2%) |
| Dec 2023 | $2.60 B(+32.8%) | $2.60 B(-0.6%) |
| Sept 2023 | - | $2.62 B(+3.0%) |
| June 2023 | - | $2.54 B(+6.0%) |
| Mar 2023 | - | $2.40 B(+22.3%) |
| Dec 2022 | $1.96 B(+6.6%) | $1.96 B(+7.3%) |
| Sept 2022 | - | $1.83 B(-0.2%) |
| June 2022 | - | $1.83 B(+1.2%) |
| Mar 2022 | - | $1.81 B(-1.7%) |
| Dec 2021 | $1.84 B(+11.8%) | $1.84 B(-2.4%) |
| Sept 2021 | - | $1.88 B(-1.6%) |
| June 2021 | - | $1.91 B(+22.1%) |
| Mar 2021 | - | $1.57 B(-4.8%) |
| Dec 2020 | $1.65 B(+6.3%) | $1.65 B(+10.6%) |
| Sept 2020 | - | $1.49 B(+0.3%) |
| June 2020 | - | $1.48 B(-2.4%) |
| Mar 2020 | - | $1.52 B(-1.8%) |
| Dec 2019 | $1.55 B(+4.6%) | $1.55 B(+10.8%) |
| Sept 2019 | - | $1.40 B(-1.7%) |
| June 2019 | - | $1.42 B(-1.9%) |
| Mar 2019 | - | $1.45 B(-2.2%) |
| Dec 2018 | $1.48 B(+54.6%) | $1.48 B(+5.2%) |
| Sept 2018 | - | $1.41 B(-1.5%) |
| June 2018 | - | $1.43 B(+56.7%) |
| Mar 2018 | - | $912.46 M(-4.7%) |
| Dec 2017 | $957.49 M(+17.8%) | $957.49 M(+12.0%) |
| Sept 2017 | - | $854.89 M(-2.3%) |
| June 2017 | - | $875.26 M(-0.8%) |
| Mar 2017 | - | $882.19 M(+8.5%) |
| Dec 2016 | $812.90 M(+8.8%) | $812.90 M(+15.5%) |
| Sept 2016 | - | $703.95 M(+0.6%) |
| June 2016 | - | $699.90 M(-2.5%) |
| Mar 2016 | - | $717.66 M(-3.9%) |
| Dec 2015 | $747.11 M(+7.0%) | $747.11 M(+0.6%) |
| Sept 2015 | - | $742.59 M(+9.9%) |
| June 2015 | - | $675.94 M(-0.5%) |
| Mar 2015 | - | $679.58 M(-2.6%) |
| Dec 2014 | $698.03 M(+48.9%) | $698.03 M(+55.5%) |
| Sept 2014 | - | $449.03 M(-0.4%) |
| June 2014 | - | $450.92 M(-2.1%) |
| Mar 2014 | - | $460.51 M(-1.8%) |
| Dec 2013 | $468.77 M(+29.2%) | $468.77 M(-2.4%) |
| Sept 2013 | - | $480.47 M(+24.0%) |
| June 2013 | - | $387.57 M(+10.1%) |
| Mar 2013 | - | $351.87 M(-3.0%) |
| Dec 2012 | $362.92 M(+15.8%) | $362.92 M(+15.1%) |
| Sept 2012 | - | $315.40 M(-0.8%) |
| June 2012 | - | $318.08 M(-0.6%) |
| Mar 2012 | - | $319.94 M(+2.1%) |
| Dec 2011 | $313.46 M(+2.5%) | $313.46 M(-1.7%) |
| Sept 2011 | - | $318.96 M(+0.5%) |
| June 2011 | - | $317.36 M(+14.1%) |
| Mar 2011 | - | $278.24 M(-9.1%) |
| Dec 2010 | $305.94 M(-13.9%) | $305.94 M(-5.0%) |
| Sept 2010 | - | $322.15 M(-6.4%) |
| June 2010 | - | $344.12 M(+9.1%) |
| Mar 2010 | - | $315.29 M(-11.2%) |
| Dec 2009 | $355.12 M(-24.4%) | $355.12 M(-5.5%) |
| Sept 2009 | - | $375.75 M(-6.8%) |
| June 2009 | - | $403.34 M(-4.4%) |
| Mar 2009 | - | $421.84 M(-10.2%) |
| Dec 2008 | $469.90 M(+89.0%) | $469.90 M(-1.5%) |
| Sept 2008 | - | $476.94 M(-6.3%) |
| June 2008 | - | $509.23 M(+55.3%) |
| Mar 2008 | - | $327.95 M(+31.9%) |
| Dec 2007 | $248.62 M | $248.62 M(+22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2007 | - | $202.82 M(+0.9%) |
| June 2007 | - | $201.04 M(-25.7%) |
| Mar 2007 | - | $270.47 M(+71.2%) |
| Dec 2006 | $158.00 M(-3.5%) | $158.00 M(+2.5%) |
| Sept 2006 | - | $154.17 M(-1.5%) |
| June 2006 | - | $156.45 M(-1.5%) |
| Mar 2006 | - | $158.79 M(-3.0%) |
| Dec 2005 | $163.71 M(-41.6%) | $163.71 M(-5.6%) |
| Sept 2005 | - | $173.34 M(-36.0%) |
| June 2005 | - | $270.71 M(-3.2%) |
| Mar 2005 | - | $279.80 M(-0.3%) |
| Dec 2004 | $280.56 M(+4.8%) | $280.56 M(+2.8%) |
| Sept 2004 | - | $272.91 M(+1.7%) |
| June 2004 | - | $268.35 M(+1.2%) |
| Mar 2004 | - | $265.17 M(-1.0%) |
| Dec 2003 | $267.76 M(-5.5%) | $267.76 M(+3.0%) |
| Sept 2003 | - | $260.03 M(+0.8%) |
| June 2003 | - | $258.02 M(-8.1%) |
| Mar 2003 | - | $280.82 M(-0.8%) |
| Dec 2002 | $283.21 M(+46.0%) | $283.21 M(+11.5%) |
| Sept 2002 | - | $253.96 M(-1.1%) |
| June 2002 | - | $256.86 M(+30.5%) |
| Mar 2002 | - | $196.75 M(+1.4%) |
| Dec 2001 | $193.96 M(+65.9%) | $193.96 M(+10.0%) |
| Sept 2001 | - | $176.38 M(+24.6%) |
| June 2001 | - | $141.60 M(+19.1%) |
| Mar 2001 | - | $118.90 M(+1.7%) |
| Dec 2000 | $116.89 M(+14.3%) | $116.89 M(+5.7%) |
| Sept 2000 | - | $110.61 M(+3.1%) |
| June 2000 | - | $107.27 M(+3.2%) |
| Mar 2000 | - | $103.96 M(+1.6%) |
| Dec 1999 | $102.31 M(+2.0%) | $102.31 M(-1.1%) |
| Sept 1999 | - | $103.40 M(+2.9%) |
| June 1999 | - | $100.50 M(+1.9%) |
| Mar 1999 | - | $98.60 M(-1.7%) |
| Dec 1998 | $100.30 M(+20.8%) | $100.30 M(+5.7%) |
| Sept 1998 | - | $94.90 M(-9.5%) |
| June 1998 | - | $104.90 M(+36.8%) |
| Mar 1998 | - | $76.70 M(-7.6%) |
| Dec 1997 | $83.00 M(+93.5%) | $83.00 M(+48.5%) |
| Sept 1997 | - | $55.90 M(-2.1%) |
| June 1997 | - | $57.10 M(+22.0%) |
| Mar 1997 | - | $46.80 M(+9.1%) |
| Dec 1996 | $42.90 M(+81.0%) | $42.90 M(+72.3%) |
| Sept 1996 | - | $24.90 M(-3.5%) |
| June 1996 | - | $25.80 M(-5.1%) |
| Mar 1996 | - | $27.20 M(+14.8%) |
| Dec 1995 | $23.70 M(+15.0%) | $23.70 M(-11.9%) |
| Sept 1995 | - | $26.90 M(+32.5%) |
| June 1995 | - | $20.30 M(+3.0%) |
| Mar 1995 | - | $19.70 M(-4.4%) |
| Dec 1994 | $20.60 M(+1.5%) | $20.60 M(+6.2%) |
| Sept 1994 | - | $19.40 M(+16.9%) |
| June 1994 | - | $16.60 M(-3.5%) |
| Mar 1994 | - | $17.20 M(-15.3%) |
| Dec 1993 | $20.30 M(+29.3%) | $20.30 M(+21.6%) |
| Sept 1993 | - | $16.70 M(+17.6%) |
| June 1993 | - | $14.20 M(-0.7%) |
| Mar 1993 | - | $14.30 M(-8.9%) |
| Dec 1992 | $15.70 M(+8.3%) | $15.70 M(+0.6%) |
| Sept 1992 | - | $15.60 M(+3.3%) |
| June 1992 | - | $15.10 M(+4.9%) |
| Mar 1992 | - | $14.40 M(-0.7%) |
| Dec 1991 | $14.50 M(+457.7%) | $14.50 M(+55.9%) |
| Sept 1991 | - | $9.30 M(-7.9%) |
| June 1991 | - | $10.10 M(+62.9%) |
| Mar 1991 | - | $6.20 M(+138.5%) |
| Dec 1990 | $2.60 M | $2.60 M |
FAQ
- What is Ionis Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual total liabilities year-on-year change?
- What is Ionis Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly total liabilities year-on-year change?
What is Ionis Pharmaceuticals annual total liabilities?
The current annual total liabilities of IONS is $2.60 B
What is the all time high annual total liabilities for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual total liabilities is $2.60 B
What is Ionis Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, IONS annual total liabilities has changed by +$642.40 M (+32.76%)
What is Ionis Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of IONS is $2.42 B
What is the all time high quarterly total liabilities for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly total liabilities is $2.62 B
What is Ionis Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, IONS quarterly total liabilities has changed by -$199.88 M (-7.63%)